Prof. Max E. Scheulen is the Secretary of the CDDF
He is Hematologist and Medical Oncologist as well as Biochemist and Toxicologist by training and currently Professor of Internal Medicine and Leader of the Clinical Phase I-Unit of the Department of Internal Medicine (Cancer Research) at the West German Cancer Center (WGCC) at the University Hospital of Essen.
He has established the Clinical Phase I-Unit as well as the Laboratory for the Pharmacology of Antineoplastic Drugs (LPhAD) at the WGCC in Essen.
He is founding member oft he Central European Society for Anticancer Drug Research (CESAR-EWIV) in 2000 of which he was President from 2005 until 2009.
In addition, he has published more than 110 papers in peer-reviewed scientific journals and has chaired numerous international scientific meetings.
- Early Clinical Drug Development
- Translational Research
- Identification of Biomarkers and Surrogate Markers
- Mechanisms of Drug Resistance
Contact Prof. Max E. Scheulen